Overview
eXmoor Pharma is a full-service CDMO specializing in cell and gene therapy manufacturing, offering end-to-end solutions from CMC strategy and process development to GMP production and facility design. Founded in 2004 and headquartered in Bristol, UK, the company supports innovators with over 20 years of consultancy experience, having completed 500+ projects for 150+ organizations. Their flexible GMP facility includes Grade C cleanrooms for viral vectors, autologous, and allogeneic therapies, with plans to expand to 200 employees by 2027.
Frequently asked questions
- What services does eXmoor Pharma offer for cell and gene therapy?
- eXmoor provides end-to-end services including CMC strategy, process and analytical development, GMP manufacturing, and facility design to support therapy development from concept to commercialization.
- What are eXmoor Pharma's GMP manufacturing capabilities?
- Their Bristol facility features four independent Grade C cleanrooms for viral vector, autologous, and allogeneic cell therapies, plus fill-finish areas and QC labs for scalable, compliant production.
- Where is eXmoor Pharma located and what is their experience?
- Headquartered in Bristol, UK, eXmoor was founded in 2004, specialized in CGT since 2007, and has completed over 500 projects for 150+ organizations with 80 employees growing to 200 by 2027.